Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing FacilityRead article
Orphan Drug Development
Thank you for getting in touch.
If you have not heard from us in the next 48 hours, do not hesitate to call us on
UK +44 (0)115 974 9000 / US +1-800-769-3518
At Quotient Sciences we have supported over 50 development programs for rare disease in the past 5 years. Our extensive formulation know-how, clinical pharmacology expertise, coupled with our agile and flexible approach to clinical and commercial manufacturing, makes us the ideal partner.
From pre-formulation and formulation development through clinical development and scale up for commercial manufacturing we provide an end-to-end solution for the development of orphan drug products. Our extensive expertise and capabilities for orphan drug development includes:
Pre-formulation and API characterisation.
Formulation and process development.
First-in-human clinical testing and acceleration into POC trials.
Bespoke clinical manufacturing and supply (Phase I-III) of drug products into patient trials.
Rapid scale-up and commercial manufacturing of low-volume products.